Clinical Trial Update: Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of an investigational drug for multiple myeloma in patients who have relapsed after an allogeneic stem cell transplant; the trial is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Multiple Myeloma, Allogeneic Stem Cell Transplantation | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING